NDC properties for NDC 9 55513-267
NDC item 55513026701
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-01 |
| NDC Item | 55513026701 |
| packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |
NDC item 55513026710
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-10 |
| NDC Item | 55513026710 |
| packaging | 10 VIAL in 1 PACKAGE (55513-267-10) / 1 mL in 1 VIAL (55513-267-01) |
| BLA | BLA103234 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |
NDC item 55513026720
| NDC 9 | 55513-267 |
|---|---|
| NDC 10 | 55513-267-20 |
| NDC Item | 55513026720 |
| packaging | 10 VIAL in 1 PACKAGE (55513-267-20) / 1 mL in 1 VIAL (55513-267-01) |
| BLA | BLA103234 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1990-04-30 |
| Marketing status | ACTIVE |